Research of Pathogenesis and Novel Therapeutics in Arthritis 2.0
1
Department of Pharmacology, School of Medicine, China Medical University, Taichung 40001, Taiwan
2
Chinese Medicine Research Center, China Medical University, Taichung 40001, Taiwan
3
Department of Biotechnology, College of Health Science, Asia University, Taichung 41354, Taiwan
Int. J. Mol. Sci. 2020, 21(21), 8125; https://doi.org/10.3390/ijms21218125
Received: 26 October 2020
/
Accepted: 28 October 2020
/
Published: 30 October 2020
(This article belongs to the Special Issue Research of Pathogenesis and Novel Therapeutics in Arthritis 2.0)
Arthritis has a high prevalence globally and includes over 100 types, the most common of which are rheumatoid arthritis, osteoarthritis, psoriatic arthritis, and inflammatory arthritis. All types of arthritis share common features of disease, including monocyte infiltration, inflammation, synovial swelling, pannus formation, stiffness in the joints and articular cartilage destruction. The exact etiology of arthritis remains unclear, and no cure exists as of yet. Anti-inflammatory drugs (NSAIDs and corticosteroids) are commonly used in the treatment of arthritis. However, these drugs are associated with significant side effects, such as gastric bleeding and an increased risk for heart attack and other cardiovascular problems. It is therefore crucial that we continue to research the pathogenesis of arthritis and seek to discover novel modes of therapy. This editorial summarizes and discusses the themes of the 27 articles published in our Special Issue “Research of Pathogenesis and Novel Therapeutics in Arthritis 2.0”, a continuation of our 2019 Special Issue “Research of Pathogenesis and Novel Therapeutics in Arthritis”. These Special Issues detail important novel research discoveries that contribute to our current understanding of arthritis.
View Full-Text
Keywords:
arthritis; treatment; molecular mechanisms; biomarkers; inflammatory cytokines; prevention
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Tang, C.-H. Research of Pathogenesis and Novel Therapeutics in Arthritis 2.0. Int. J. Mol. Sci. 2020, 21, 8125. https://doi.org/10.3390/ijms21218125
AMA Style
Tang C-H. Research of Pathogenesis and Novel Therapeutics in Arthritis 2.0. International Journal of Molecular Sciences. 2020; 21(21):8125. https://doi.org/10.3390/ijms21218125
Chicago/Turabian StyleTang, Chih-Hsin. 2020. "Research of Pathogenesis and Novel Therapeutics in Arthritis 2.0" International Journal of Molecular Sciences 21, no. 21: 8125. https://doi.org/10.3390/ijms21218125
Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
